Elimination of vascular fibrointimal hyperplasia by somatostatin receptor 1,4-selective agonist.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 16, Issue 7, 2002, Pages 724-726

  Aavik, Einari ^a   Luoto, Nina Maria ^a   Petrov, Lubomir ^a   Aavik, Silja ^a   Patel, Yogesh C ^a   Hayry, Pekka ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CH 275; DRUG DERIVATIVE; MEMBRANE PROTEIN; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN 14, TYR(11); SOMATOSTATIN 14, TYR(11)-; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR SUBTYPE 4; SOMATOSTATIN RECEPTOR SUBTYPE-4; SOMATOSTATIN RECEPTOR TYPE 1;

ANIMAL; ARTICLE; BLOOD; BLOOD VESSEL; CAROTID ARTERY DISEASE; CELL CULTURE; CELL DIVISION; CELL MOTION; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FIBROMUSCULAR DYSPLASIA; HALF LIFE TIME; INTIMA; MALE; PATHOLOGY; PHYSIOLOGY; RAT; VASCULAR SMOOTH MUSCLE; WEIGHT GAIN; WISTAR RAT;

ANIMALS; BLOOD VESSELS; CAROTID ARTERY DISEASES; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROMUSCULAR DYSPLASIA; HALF-LIFE; MALE; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; OCTREOTIDE; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TUNICA INTIMA; WEIGHT GAIN;

MLCS; MLOWN;

EID: 0036581042     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.01-0272fje     Document Type: Article

References (0)